Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Medical Treatments (Chemotherapy, Hormonal Therapy and Biological Therapies) in Metastatic Breast Cancer Patients According to Biologic Subtype and Line of Treatment

NCT02284581 is registered in ClinicalTrials.gov with Consorzio Oncotech as lead sponsor.

NCT NCT02284581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02284581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Medical Treatments (Chemotherapy, Hormonal Therapy and Biological Therapies) in Metastatic Breast Cancer Patients According to Biologic Subtype and Line of Treatment
Lead sponsor
Consorzio Oncotech
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2015
Completion date
December 31, 2025
Enrollment
10,000 (estimated)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer